No Data
US Stock MarketDetailed Quotes
ADCT ADC Therapeutics
Watchlist
0.728
-0.041-5.27% Trading 09/21 11:35 ET
0.790High0.700Low140.05KVolume
0.790Open0.768Pre Close101.07KTurnover0.28%Turnover RatioLossP/E (TTM)58.67MMarket Cap5.75052wk HighLossP/E (Static)80.64MShares0.70052wk Low-6.80P/B36.62MFloat Cap56.590Historical High--Dividend TTM50.34MShs Float0.700Historical Low--Div YieldTTM11.72%Amplitude0.721Avg Price1Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About ADC Therapeutics Company
ADC Therapeutics SA is a clinical-stage biotechnology company. It engages in the research and development and commercialization of targeted antibody drug conjugates for patients with hematological malignancies and solid tumors. Its clinical-stage product candidates include loncastuximab tesirine, camidanlumab tesirine, and ADCT-602. The company was founded by Christopher Martin on June 6, 2011 and is headquartered in Epalinges, Switzerland.
Revenue Breakdown
Business
Unit:USD
Stock NameYOYOperating income%
Single segment--209.91M100.00%
News
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's session, 275 companies made new 52-week lows. Areas of Significance In Today's 52-Week Lows: ARM Holdings (NASDAQ:ARM) was the largest firm by market cap to set a new 52-week low.Tr
Analysts Offer Insights on Healthcare Companies: Werewolf Therapeutics (HOWL), Enanta Pharmaceuticals (ENTA) and ADC Therapeutics (ADCT)
HC Wainwright & Co. Reiterates Buy on ADC Therapeutics, Maintains $12 Price Target
HC Wainwright & Co. analyst Robert Burns reiterates ADC Therapeutics with a Buy and maintains $12 price target.
Comments
ColumnsADC Therapeutics | LOTIS-9 Combo Study Takes a Breather on Enrollment
ADCT before market open today announced its voluntary pause in the enrollment of the LOTIS-9 combo trial of Zynlonta and Rituxan (Lonca-R) in front-line unfit/frail DLBCL. We also caught up with the mgmt team this morning for more insights. Briefly, the pause was driven by higher-than-expected respiratory-related TEAEs (incl. 7 Gr 5, 5 Gr 3/4) after a recent data review of 40 pts. Of the 12 TEAEs, 1 Gr 5 case was deemed to be r...
$ADC Therapeutics(ADCT.US$ big space to rebound.
Read more
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--